Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services company, has announced its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference. Jim Davis, Chairman, CEO and President, will represent the company in a fireside chat on September 6, 2024, at 10:45 a.m. Eastern Time in New York City.
During the session, Davis will discuss Quest's strategy, performance, and current market trends. The event will be webcast live and made available on Quest's investor relations page at ir.QuestDiagnostics.com. For those unable to attend, an archived version of the webcast will be accessible within 24 hours after the event and remain available until October 6, 2024.
Quest Diagnostics (NYSE: DGX), un'azienda leader nei servizi di informazione diagnostica, ha annunciato la sua partecipazione alla 22ª Conferenza Globale Annuale sulla Sanità di Morgan Stanley. Jim Davis, Presidente, CEO e Direttore Generale, rappresenterà l'azienda in un colloquio informale il 6 settembre 2024, alle 10:45 ora orientale a New York City.
Durante la sessione, Davis discuterà della strategia, delle prestazioni e delle tendenze attuali del mercato di Quest. L'evento sarà trasmesso in diretta e sarà reso disponibile nella pagina delle relazioni con gli investitori di Quest su ir.QuestDiagnostics.com. Per coloro che non possono partecipare, una versione archiviata della trasmissione sarà accessibile entro 24 ore dopo l'evento e rimarrà disponibile fino al 6 ottobre 2024.
Quest Diagnostics (NYSE: DGX), una empresa líder en servicios de información diagnóstica, ha anunciado su participación en la 22ª Conferencia Anual Global de Salud de Morgan Stanley. Jim Davis, Presidente, CEO y Director Ejecutivo, representará a la empresa en una charla informal el 6 de septiembre de 2024, a las 10:45 a.m. hora del Este en la ciudad de Nueva York.
Durante la sesión, Davis discutirá sobre la estrategia, el rendimiento y las tendencias actuales del mercado de Quest. El evento será transmitido en vivo y estará disponible en la página de relaciones con inversores de Quest en ir.QuestDiagnostics.com. Para aquellos que no puedan asistir, una versión archivada de la transmisión estará accesible dentro de las 24 horas siguientes al evento y permanecerá disponible hasta el 6 de octubre de 2024.
퀘스트 진단 (NYSE: DGX), 선도적인 진단 정보 서비스 회사가 모건 스탠리 제22회 연례 글로벌 헬스케어 컨퍼런스에 참석한다고 발표했습니다. 짐 데이비스 회장, CEO 및 사장이 2024년 9월 6일 오전 10시 45분 (동부 표준시)에 뉴욕에서 회사 대표로 대담 형식의 세션에 참석합니다.
세션 중에 데이비스는 퀘스트의 전략, 성과 및 현재 시장 트렌드에 대해 논의할 것입니다. 이 이벤트는 실시간 웹 캐스트로 진행되며 퀘스트의 투자자 관계 페이지 ir.QuestDiagnostics.com에서 확인할 수 있습니다. 참석이 불가능한 분들을 위해, 웹 캐스트의 아카이브된 버전은 행사 후 24시간 이내에 접근 가능하며 2024년 10월 6일까지 이용할 수 있습니다.
Quest Diagnostics (NYSE: DGX), une entreprise leader dans les services d'information diagnostique, a annoncé sa participation à la 22ème Conférence Annuelle Mondiale sur la Santé de Morgan Stanley. Jim Davis, Président, PDG et Directeur Général, représentera l'entreprise lors d'une discussion informelle le 6 septembre 2024 à 10h45, heure de l'Est à New York.
Lors de cette session, Davis discutera de la stratégie, de la performance et des tendances actuelles du marché de Quest. L'événement sera diffusé en direct et sera mis à disposition sur la page des relations avec les investisseurs de Quest à l'adresse ir.QuestDiagnostics.com. Pour ceux qui ne peuvent pas assister, une version archivée de la diffusion sera accessible dans les 24 heures suivant l'événement et restera disponible jusqu'au 6 octobre 2024.
Quest Diagnostics (NYSE: DGX), ein führendes Unternehmen im Bereich diagnostischer Informationsdienste, hat seine Teilnahme an der 22. jährlichen globalen Gesundheitskonferenz von Morgan Stanley angekündigt. Jim Davis, Vorsitzender, CEO und Präsident, wird das Unternehmen in einem informellen Gespräch am 6. September 2024 um 10:45 Uhr Eastern Time in New York City vertreten.
Während der Sitzung wird Davis über die Strategie, Leistung und aktuellen Markttrends von Quest sprechen. Die Veranstaltung wird live übertragen und auf der Investor Relations-Seite von Quest unter ir.QuestDiagnostics.com verfügbar sein. Für diejenigen, die nicht teilnehmen können, wird eine archivierte Version des Webcasts innerhalb von 24 Stunden nach der Veranstaltung zugänglich sein und bis zum 6. Oktober 2024 verfügbar bleiben.
- None.
- None.
The fireside chat and Q&A session will be webcast live during the conference and will be available on the company's investor relations page which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 6, 2024.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-morgan-stanley-22nd-annual-global-healthcare-conference-302233363.html
SOURCE Quest Diagnostics
FAQ
When is Quest Diagnostics (DGX) speaking at the Morgan Stanley Healthcare Conference?
Who will represent Quest Diagnostics (DGX) at the Morgan Stanley Healthcare Conference?
How can I watch Quest Diagnostics' (DGX) presentation at the Morgan Stanley Healthcare Conference?
Until when will the archived webcast of Quest Diagnostics' (DGX) presentation be available?
